PRKAA1 and metabolic dysfunction-associated steatotic liver disease: Compiling results in vivo and ex vivo have shown that BBR could alleviate metabolic disorders, including obesity, insulin resistance, NAFLD and hyperlipidemia, by stimulating AMPK activity51.